[克隆进化在慢性髓性白血病的临床意义]
1Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University.
概括
慢性髓性白血病 (CML) 涉及费城染色体和BCR::ABL1融合基因,驱动白血病细胞生长. 基因突变,如ASXL1,影响CML的治疗反应和患者的治疗结果.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 慢性髓性白血病 (CML) 是一种由费城染色体和BCR::ABL1融合基因定义的血液癌症.
- 这种遗传异常导致无法控制的氨酸激酶活性和白血病细胞的增殖.
- CML从慢性阶段发展为爆发性危机,经常获得额外的突变.
研究的目的:
- 调查基因突变在CML进展和治疗耐药性的作用.
- 了解像ASXL1这样的突变如何影响患者的预后和氨酸激酶抑制剂敏感性.
- 探索CML患者分层和个性化治疗策略的应用.
主要方法:
- 在CML患者样本中分析遗传异常.
- 突变状态与临床阶段的相关性 (慢性与爆发性危机).
- 对突变对氨酸激酶抑制剂敏感性和患者结局的影响的评估.
主要成果:
- 在约20%的慢性阶段CML中存在ASXL1突变.
- 爆发性危机性CML经常表现出额外的遗传突变,包括ASXL1和RUNX1.1.
- 特定的遗传突变会影响白血病细胞对氨酸激酶抑制剂的敏感性.
结论:
- 遗传突变在CML的发病和进展中起着至关重要的作用.
- 突变影响治疗疗效和患者预后,突出显示了它们的临床意义.
- 识别这些突变可以实现更好的患者分层和个性化的CML治疗.
相关概念视频
Disorders of Leukocytes
989
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
989
T Cell Activation and Clonal Selection
838
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
838
Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
Lineage Commitment
3.0K
Commitment is the process whereby stem cells:
3.0K
Cancers Originate from Somatic Mutations in a Single Cell
12.3K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.3K


